ArticleInvestigational new drugs2009

Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo.

Xishan Xiong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.